Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Etoposide | 19.9526 | uM | 3 | 156.25 | 49.48 | 63.00 | 100.00 | 0.6300 | 0.2687 |
| BT-20 | PLX-4720 | 0.01 | uM | 3 | 156.25 | 49.48 | 134.00 | 100.00 | 1.3400 | 1.6684 |
| BT-20 | PLX-4720 | 3.1623 | uM | 3 | 156.25 | 49.48 | 95.00 | 100.00 | 0.9500 | 0.9015 |
| BT-20 | Nilotinib | 10 | uM | 3 | 156.25 | 49.48 | 453.00 | 100.00 | 4.5300 | 7.8586 |
| BT-20 | NVP-TAE684 | 0.0016596 | uM | 3 | 156.25 | 49.48 | 142.00 | 100.00 | 1.4200 | 1.8252 |
| BT-20 | Nilotinib | 1 | uM | 3 | 156.25 | 49.48 | 146.00 | 100.00 | 1.4600 | 1.9036 |
| BT-20 | NVP-TAE684 | 0.1 | uM | 3 | 156.25 | 49.48 | 97.00 | 100.00 | 0.9700 | 0.9409 |
| BT-20 | PLX-4720 | 10 | uM | 3 | 156.25 | 49.48 | 122.00 | 100.00 | 1.2200 | 1.4328 |
| BT-20 | Nilotinib | 19.9526 | uM | 3 | 156.25 | 49.48 | 1254.00 | 100.00 | 12.5400 | 23.1536 |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 129.00 | 100.00 | 1.2900 | 1.5702 | |
| BT-20 | NVP-TAE684 | 3.1623 | uM | 3 | 156.25 | 49.48 | 76.00 | 100.00 | 0.7600 | 0.5262 |
| BT-20 | Etoposide | 0.0033113 | uM | 3 | 156.25 | 49.48 | 97.00 | 100.00 | 0.9700 | 0.9409 |
| BT-20 | PLX-4720 | 19.9526 | uM | 3 | 156.25 | 49.48 | 67.00 | 100.00 | 0.6700 | 0.3480 |
| BT-20 | Etoposide | 3.1623 | uM | 3 | 156.25 | 49.48 | 64.00 | 100.00 | 0.6400 | 0.2885 |
| BT-20 | NVP-TAE684 | 10 | uM | 3 | 156.25 | 49.48 | 33.00 | 100.00 | 0.3300 | -0.3290 |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 80.00 | 100.00 | 0.8000 | 0.6053 | |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 42.00 | 100.00 | 0.4200 | -0.1491 | |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 189.00 | 297.50 | 0.6353 | 0.3356 | |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 187.00 | 297.50 | 0.6286 | 0.3230 | |
| BT-20 | Etoposide | 10 | uM | 3 | 312.50 | 136.54 | 159.00 | 297.50 | 0.5345 | 0.1451 |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 288.00 | 297.50 | 0.9681 | 0.9431 | |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 336.00 | 297.50 | 1.1294 | 1.2288 | |
| BT-20 | Etoposide | 1 | uM | 3 | 312.50 | 136.54 | 261.00 | 297.50 | 0.8773 | 0.7801 |
| BT-20 | NVP-TAE684 | 0.31623 | uM | 3 | 312.50 | 136.54 | 332.00 | 297.50 | 1.1160 | 1.2052 |
| BT-20 | Nilotinib | 0.031623 | uM | 3 | 312.50 | 136.54 | 340.00 | 297.50 | 1.1429 | 1.2524 |